Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-11-000436
Filing Date
2011-05-26
Accepted
2011-05-26 19:30:02
Documents
1
Period of Report
2011-05-24

Document Format Files

Seq Description Document Type Size
1 form4-05262011_040549.html 4  
1 form4-05262011_040549.xml 4 4558
  Complete submission text file 0001415889-11-000436.txt   6031
Mailing Address C?O GUILFORD PHARMACEUTICALS INC 6611 TRIBUTARY STREET BALTIMORE MD 21224
Business Address
Spengler William (Reporting) CIK: 0001297399 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53290 | Film No.: 11875781

Mailing Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618
Business Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618 949-419-0288
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products